Baillie Gifford - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 253 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q4 2022$4,547
-43.2%
3850.0%0.00%
Q3 2022$8,000
-33.3%
3850.0%0.00%
Q2 2022$12,000
-25.0%
3850.0%0.00%
Q1 2022$16,000
-5.9%
3850.0%0.00%
Q4 2021$17,000
-10.5%
3850.0%0.00%
Q3 2021$19,000
-29.6%
385
-9.0%
0.00%
Q2 2021$27,000
-30.8%
4230.0%0.00%
Q1 2021$39,000
+8.3%
423
+3.9%
0.00%
Q4 2020$36,0004070.00%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q1 2022
NameSharesValueWeighting ↓
SNYDER CAPITAL MANAGEMENT L P 962,696$31,615,0001.92%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 486,609$15,979,0000.98%
LOMBARDIA CAPITAL PARTNERS LLC 272,465$8,948,0000.92%
Matarin Capital Management, LLC 227,687$7,477,241,0000.84%
Campbell & CO Investment Adviser LLC 6,434$211,0000.65%
RICE HALL JAMES & ASSOCIATES, LLC 390,100$12,811,0000.65%
Nine Chapters Capital Management LLC 10,100$332,0000.56%
Pine River Capital Management L.P. 284,180$9,332,0000.34%
Capital Impact Advisors, LLC 24,637$809,0000.34%
GLENMEDE TRUST CO NA 1,470,747$48,297,0000.26%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders